The manager of a table-topping biotechnology trust has said careful use of the closed-ended structure has enabled him to outperform, including holding half of his assets in just five stocks.
Daniel Koller, who leads the management team for the BB Biotech trust, said that the independence of the closed-ended structure allowed him to take significant positions of 10% or more in selected stocks....
Industry Voice: Chris Taylor discusses the outlook for Japan, explaining why corporates are producing record aggregate profits and profits growth.
Comes in on 9 December 2019
Latest news and analysis
Primarily smart-beta products
Revealed – successes across all 11 categories